Genesis Therapeutics has filed a notice of an exempt offering of securities to raise $224,025,681.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Genesis Therapeutics is raising $224,025,681.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Evan Feinberg played a…
